is an essential function of the renal microcirculation that has been previously shown to be blunted by excessive dietary salt. Endogenous endothelin 1 (ET-1) is increased following a high-salt (HS) diet and contributes to the control of RBF but the differential effects of ET-1 on renal microvessel autoregulation in response to HS remain to be established. We hypothesized that a HS diet increases endothelin receptor activation in normal Sprague-Dawley rats and blunts autoregulation of RBF. The role of ET-1 in the blunted autoregulation produced by a HS diet was assessed in vitro and in vivo using the blood-perfused juxtamedullary nephron preparation and anesthetized rats, respectively. Using highly selective antagonists, we observed that blockade of either ETA or ETB receptors was sufficient to restore normal autoregulatory behavior in afferent arterioles from HS-fed rats. Additionally, normal autoregulatory behavior was restored in vivo in HS-fed rats by simultaneous ET A and ETB receptor blockade, whereas blockade of ETB receptors alone showed significant improvement of normal autoregulation of RBF. Consistent with this observation, autoregulation of RBF in ET B receptor-deficient rats fed HS was similar to both ETB-deficient rats and transgenic control rats on normal-salt diets. These data support the hypothesis that endogenous ET-1, working through ET B and possibly ET A receptors, contributes to the blunted renal autoregulatory behavior in rats fed a HS diet.
EXCESS SALT CONSUMPTION in Western diets is prevalent, with
Americans consuming an average of twice the American Heart Association recommended amount of sodium per day (2) . Reducing dietary sodium is linked to significant reductions in systolic blood pressure in hypertensive humans (2, 24, 51) . Excess dietary NaCl can also increase systolic blood pressure in salt-sensitive humans (2, 5) and animals and can contribute to hypertensive renal injury (1) . An important defense mechanism for prevention of hypertensive kidney injury is the inherent ability to adjust preglomerular renal vascular resistance to autoregulate renal blood flow (RBF) and glomerular capillary pressure in the face of changes in renal arterial pressure (RAP) (4, 28, 31, 40, 45) . Autoregulation involves two or more mechanisms working in concert to stabilize RBF and glomerular filtration rate when challenged with fluctuations in RAP (31, 40, 45) . For example, increases in RAP result in renal vasoconstriction, largely involving afferent arterioles. This increase in renal vascular resistance offsets the increase in arterial pressure to maintain a stable RBF and glomerular filtration rate. The two best understood mechanisms of renal autoregulation are the myogenic response of preglomerular vascular smooth muscle and the tubuloglomerular feedback (TGF) mechanism that influences afferent arteriole resistance via signaling from the macula densa cells of the distal nephron (13, 31, 43, 45, 57) . While the existence of the autoregulatory phenomenon is well-accepted, the effect of salt consumption on autoregulatory behavior is not well-understood.
Since its discovery in the 1980's (25, 62) , endothelin has been shown to strongly influence renal regulation of salt and water homeostasis (35, 44, 53) . Additionally, high-salt (HS) intake reportedly increases plasma endothelin 1 (ET-1) modestly in rats and humans (12, 39) . Endothelin is produced by many renal cell types and is a potent vasoconstrictor with both intrarenal and extrarenal effects (20, 29, 35-37, 41, 59) . Studies show that HS intake increases ET-1 levels in the vascular wall (60) and stimulates ET-1 release in the renal medulla (6) .
Endothelin receptors are divided into two main subtypes named ET A and ET B (35, 36, 42) . Both receptor subtypes are G protein-coupled and they are differentially expressed by renal tissue (35, 36, 42) . ET-1 induces a long-lasting vasoconstriction of afferent and efferent arterioles through activation of ET A receptors located on vascular smooth muscle cells (14, 22, 27, 29, 38) . ET B receptor activation can exert vasoconstrictor and/or vasodilatory influences depending on expression of ET B receptors by endothelium or vascular smooth muscle. ET B receptors are expressed by the renal microvasculature and expression increases in kidneys from rats fed a HS diet (14, 29, 56) . Nevertheless, the relative expression levels between the endothelium and vascular smooth muscle tissues are not clear. Conversely, another study showed that a HS diet increases the ratio of ET A to ET B receptors in the kidneys of spontaneously hypertensive rats (53) . Endothelin has been shown to play a role in autoregulation through an ET B -dependent mechanism that is purported to signal through nitric oxide (NO) and modulates the myogenic response (58) . Taken together, these observations led to the hypothesis that a HS diet increases endothelin receptor activation in normal Sprague-Dawley rats and blunts autoregulation of RBF. Experiments were performed to determine whether increased salt intake leads to an endothelin receptor-dependent decrease in afferent arteriole autoregulatory behavior in vitro and whether this effect could be demonstrated in vivo relating to whole kidney autoregulation of RBF.
METHODS
Animals. Experiments were performed using male Sprague-Dawley rats (270 -330 g; Charles River Laboratories, Raleigh, NC). All animals were cared for in accordance with National Institutes of Health guidelines, and all procedures were approved by the Georgia Regents University and University of Alabama at Birmingham Institutional Animal Care and Use Committees.
Diet. Rats were fed either a normal-salt diet (NS; 0.8% NaCl) or HS (8% NaCl) diet for 14 days before each experiment and had ad libitum access to tap water.
In vitro blood-perfused juxtamedullary nephron preparation. Videomicroscopy experiments were performed in vitro using the bloodperfused juxtamedullary nephron technique, as previously described (19) . The ET A receptor antagonist BQ-123 (1.0 M; Sigma, St. Louis, MO) or the ETB receptor antagonist BQ-788 (1.0 M; Sigma) were added to the reconstituted blood used to perfuse the prepared kidney. Experiments were designed to assess autoregulatory behavior, defined as the change in afferent arteriole diameter induced by step changes in renal perfusion pressure (pressure/diameter relationship). To assess autoregulatory function, afferent arteriolar diameters were measured during a control period at renal perfusion pressure of 100 mmHg and then at pressures ranging from 65 to 170 mmHg stepped in 15-mmHg increments over successive 5-min periods. Afferent arteriolar diameter was calculated from the average of measurements taken at a single site at 12-s intervals during the last 2 min of the 5-min pressure step.
In vivo autoregulation of RBF. Rats were anesthetized with pentobarbital sodium (50 mg/kg ip; Hospira, Lake Forest, IL) and placed on a servo-controlled heating table to maintain body temperature (37-38°C) as measured by a rectal probe (Physitemp, Clifton, NJ). A tracheotomy tube (PE-205) was inserted into the trachea to ensure a patent airway. The left femoral artery and right carotid artery were cannulated (PE-50) for continuous recording of arterial pressure both below (femoral) and above (carotid) an adjustable aortic screw clamp. Two catheters were inserted into the right jugular vein for infusion of maintenance solutions and for infusion of endothelin agonists and antagonists. The maintenance catheter (PE-50 tubing) delivers 6% bovine serum albumin (Sigma) in phosphate-buffered saline infused at 20 l/min during surgery and then reduced to 10 l/min during the experimental periods. The second jugular catheter (PE-10) was used for infusion of BQ-123 (30 nmol·kg Ϫ1 ·min Ϫ1 ; 10 l/min; PBS) or BQ-788 (30 nmol·kg Ϫ1 ·min Ϫ1 ; 10 l/min; 7% EtOH) for blockade of ETA and ETB receptors, respectively. In all cases, the total infusion volume during the experimental periods was 20 l/min.
The abdomen was opened by a midline incision. A segment of the aorta between the left and right renal arteries was separated from the surrounding connective tissue and vena cava. An adjustable screw clamp vascular occluder (Vestavia Scientific, Vestavia Hills, AL) was placed around the aorta to adjust left RAP as monitored by the femoral artery cannula. The left renal artery was separated from the renal vein and an ultrasonic flow probe (MA1PRB, Transonic Systems, Ithaca, NY) was installed to measure whole kidney RBF. Arterial pressure (carotid and femoral), heart rate, and RBF were continuously recorded by an eight-channel PowerLab (ADInstruments, Colorado Springs, CO). Upon completion of the surgical procedures, the animals were allowed to stabilize for 60 min before experiments were started.
Assessment of autoregulation. Whole kidney autoregulation experiments were performed to assess the impact of step reductions in RAP on RBF. The protocol used to assess whole kidney autoregulation of RBF consisted of a series of reductions in RAP to determine the RBF response of animals on normal and HS before and after endothelin receptor blockade. Control or baseline autoregulatory function was determined before administration of endothelin receptor antagonists with a 10-min control period to establish baseline mean arterial pressure (MAP) and RBF; followed by successive reductions of RAP from ambient to 105, 95, and 85 mmHg. The vascular occluder was tightened until femoral artery pressure (representing RAP) declined to each target pressure where it was maintained for 5 min. Following the period at 85 mmHg, the clamp was released to allow RAP to return to ambient. After a 10-min recovery period, selective ET A and/or ETB receptor antagonist or vehicle (7% EtOH in PBS) infusion was started and an equilibration period was allowed for blood pressure to return to at least 108 mmHg. Once blood pressure and RBF stabilized in the presence of the endothelin receptor antagonist (or vehicle), RAP was again reduced from ambient to 105, 95, and 85 mmHg followed by a 10-min recovery period. After this recovery period, we administered a 10-pmol bolus of ET-1 to verify endothelin receptor blockade. The response to bolus injection of ET-1 was calculated as the peak carotid artery pressure minus the pressure just before ET-1 injection.
A separate series of in vivo autoregulation studies was performed using ET B receptor-deficient rats, which are on the spotting lethal rat background (17) . The spotting lethal rat carries a natural 301-bp deletion in the ET B receptor gene, resulting in expression of dysfunctional ET B receptors. Rats that are homozygous (sl/sl) for this mutation exhibit a lethal phenotype of congenital intestinal agangliosis. In 1998, Gariepy et al. (17) used a dopamine-␤-hydroxylase promoter to direct transgenic ET B receptor expression only in the enteric nervous system, thereby rescuing the rats from the intestinal defect. We performed autoregulation studies using these ET B receptor-deficient rats to complement those above in assessing the role of ET B receptors on the autoregulatory impairment observed in rats on a HS diet. Littermates with functional copies of the ET B gene and positive for the transgene were used as controls (Tg control).
Autoregulatory index (AI) was calculated according to following formula:
, as previously reported (15, 19, 49, 50) . RBF1 and RAP1 indicate the values during the previous period while RBF2 and RAP2 describe the values during that period of pressure reduction. An AI of 0 means perfect autoregulation and an AI approaching 1 depicts impaired autoregulatory capability.
Statistical analyses. Data are presented as means Ϯ SE for n ϭ 7-12 rats/group. In vivo RBF data and in vitro juxtamedullary nephron data were analyzed by two-way ANOVA for repeated measures followed by (Bonferroni's) post hoc test to compare between groups. AI data were also analyzed by two-way ANOVA for repeated measures followed by (Bonferroni's) post hoc test to compare between groups. The response to bolus injection of ET-1 was analyzed using a paired t-test. P Յ 0.05 was considered statistically significant for all analyses.
RESULTS
ET A receptor blockade restores autoregulatory behavior of juxtamedullary afferent arterioles from HS rats. Acute ET A receptor blockade with BQ-123 had no significant effect on baseline afferent arteriole diameter in kidneys from NS (15.8 Ϯ 0.1 vs. 14.2 Ϯ 0.4 m with BQ-123) or HS rats (14.5 Ϯ 0.9 vs. 14.1 Ϯ 0.5 m with BQ-123) at a perfusion pressure of 100 mmHg (Fig. 1) . Figure 2 illustrates the effect of acute ET A receptor blockade on afferent arteriolar autoregulatory behavior. Increasing perfusion pressure from 65 to 170 mmHg resulted in a significant reduction in afferent arteriolar diameter to 74 Ϯ 2% of baseline in kidneys from NS rats while the diameters of arterioles from HS rats (15.3 Ϯ 1.4 m) did not decrease significantly over the same pressure range ( Figure 3 illustrates the effect of acute ET B receptor blockade on afferent arteriolar autoregulatory behavior. BQ-788 treatment normalized afferent arteriolar autoregulatory behavior in kidneys from HS rats such that arteriolar diameter declined to 12.3 Ϯ 0.7 m or 84 Ϯ 2% of control when perfusion pressure was increased to 170 mmHg (Fig. 3, A and B) . Although ET B receptor blockade slightly reduced baseline arteriolar diameter in kidneys from NS rats, the autoregulatory response was similar to that observed in control kidneys (Fig. 3, A and B) . This might reflect a tonic vasodilatory influence of ET B receptors on baseline afferent arteriole diameter.
HS blunts autoregulation of whole kidney RBF. All groups of rats used for in vivo studies exhibited statistically similar body weights on the day of the experiment. Body weights averaged between 298 Ϯ 5 to 305 Ϯ 4 g, indicating similar levels of food consumption and nutrition over the 14-day feeding schedule. Figure 4 illustrates the effect of reducing RAP on RBF. RBF was significantly greater in HS rats (12.5 Ϯ 0.6 vs. 9.8 Ϯ 0.6 ml/min for NS rats, P Ͻ 0.05; Fig. 4A ) under baseline conditions where the kidneys were perfused at ambient RAP. When the aortic screw clamp was tightened to reduce RAP to 105 mmHg, RBF declined by 5 Ϯ 1% (Fig. 4B ) in HS rats from a baseline of 12.6 Ϯ 0.6 to 11.8 Ϯ 0.6 ml/min, while it increased slightly but significantly by 2 Ϯ 1% (from 9.8 Ϯ 0.6 to 10.0 Ϯ 0.6 ml/min, P Ͻ 0.05; Fig. 4A ) in kidneys from NS rats. This trend continued when RAP was further reduced from 105 to 95 mmHg. RBF declined 16 Ϯ 3% in HS from a baseline of 12.6 Ϯ 0.6 to 10.4 Ϯ 0.6 ml/min compared with NS rats which exhibited a 4 Ϯ 2% decrease (from 9.8 Ϯ 0.6 to 9.4 Ϯ 0.6 ml/min, P Ͻ 0.05; Fig. 4A ever, the AI for HS rats was 0.50 Ϯ 0.15 and 0.80 Ϯ 0.14 over the same pressure spans, indicating significantly compromised autoregulatory function ( Fig. 5 ; P Ͻ 0.05). Figure 4 also illustrates the effects of acute blockade of both ET A and ET B on RBF autoregulation. Before endothelin receptor blockade, RBF on NS rats was efficiently autoregulated over the RAP range of ambient to 95 mmHg, whereas that of HS rats was not (Fig. 4) . Both HS and NS rats receiving combined treatment with BQ-123 and BQ-788 exhibited similar baseline RBF's despite the fact that MAP decreased significantly in both groups following endothelin receptor blocker administration ( Fig. 4A ; P Ͻ 0.05). When the screw clamp was tightened to reduce RAP to 105 mmHg in HSϩBQ-123/BQ-788 rats, RBF actually increased slightly by 3 Ϯ 2% from a baseline of 11.7 Ϯ 0.6 to 11.9 Ϯ 0.6 ml/min compared with before ET A /ET B blockade when RBF decreased by 5 Ϯ 1% (from 12.6 Ϯ 0.6 to 11.8 Ϯ 0.6 ml/min, P Ͻ 0.05; Fig. 4, A and B) . Further reduction of RAP to 95 mmHg led to a slight decline in RBF to 96 Ϯ 3% of baseline in HSϩBQ-123/BQ-788 rats from 11.9 Ϯ 0.6 to 11.4 Ϯ 0.6 ml/min compared with before ET A /ET B blockade where RBF decreased to 84% of baseline (from 11.7 Ϯ 0.6 to 10.4 Ϯ 0.6 ml/min, P Ͻ 0.05; Fig. 4, A and B) . In comparing the different groups after normalizing for baseline RBF (Fig. 4B) (Fig. 5) .
Dual ET A /ET B receptor blockade restores blunted autoregulation of RBF in HS rats.
Effect of ET A receptor blockade on blunted RBF autoregulation in HS rats. Figure 6 , A and B, illustrates the effects of selective ET A receptor blockade with BQ-123 on RBF autoregulation. ET A blockade reduced MAP from 119 Ϯ 1 to 111 Ϯ 1 mmHg (P Ͻ 0.05; Fig. 6A ) but had little effect on RBF autoregulation. When the aortic clamp was tightened to reduce RAP to ϳ105 mmHg in HSϩBQ-123 rats, RBF decreased by ϳ2% from a baseline of 11.9 Ϯ 0.2 to 11.7 Ϯ 0.6 ml/min compared with an 8 Ϯ 3% decrease (from 12.6 Ϯ 0.6 to 11.8 Ϯ 0.6 ml/min, P Ͻ 0.05; (Fig. 5) , suggesting some improvement in autoregulatory control at the higher pressures but no significant improvement in autoregulatory performance over the broader pressure span. Figure 6 , C and D, illustrates the effects of acute blockade of ET B receptors with BQ-788 on RBF autoregulation. BQ-788 had little effect on MAP but reduced baseline RBF from 12.9 Ϯ 0.2 to 9.2 Ϯ 0.2 ml/min (P Ͻ 0.05; Fig. 6C ). Reducing RAP from ambient to 105 mmHg resulted in a decline in RBF of ϳ3 Ϯ 2% from a baseline of 9.2 Ϯ 0.2 to 8.9 Ϯ 0.3 ml/min in HS rats with BQ-788 compared with 9 Ϯ 3% decrease (from 12.7 Ϯ 0.2 to 11.6 Ϯ 0.2 ml/min, P Ͻ 0.05; Fig. 6A ) before ET A receptor blockade. Similarly, when RAP was reduced to 95 mmHg, RBF only declined by 8 Ϯ 3% in HSϩBQ-788 compared with a 16 Ϯ 3% decrease observed before ET A receptor blockade (P Ͻ 0.05; Fig. 6A ). The AI for the pressure change from ambient to 105 mmHg and ambient to 95 mmHg in HS rats averaged 0.78 Ϯ 0.21 and 0.83 Ϯ 0.15 before ET B receptor blocker treatment and 0.18 Ϯ 0.32 and 0.38 Ϯ 0.19 during BQ-788 administration ( Fig. 5 ; P Ͻ 0.05).
Effect of acute ET B receptor blockade on blunted RBF autoregulation in HS rats.
Effect of an ET-1 bolus injection on carotid arterial pressure. At the end of each receptor blocker protocol, rats received a bolus injection of ET-1 (10 pmol) to determine the effect on MAP measured with the carotid artery cannula and the results are shown in Fig. 7 . Bolus injection of ET-1 in NSϩBQ-123/BQ-788 revealed no significant change (P ϭ 0.25) in MAP, indicating good blockade of ET A and ET B receptors. Vehicle control rats fed a HS diet responded to the ET-1 bolus with a significant increase in MAP of ϳ10 mmHg (P Ͻ 0.05). Similarly, MAP also increased ϳ13 mmHg in HS rats receiving BQ-788 alone (P Ͻ 0.05), suggesting that the bulk of the ET-1 effect is through ET A receptor activation. No significant change in MAP was noted in either the HSϩBQ-123/BQ-788 (P ϭ 0.29)-or the HSϩBQ-123 (P ϭ 0.90)-treated rats in response to the ET-1 bolus.
ET B receptor deficiency preserves autoregulation of RBF in HS rats. MAP under anesthesia was similar in Tg control groups and averaged 114 Ϯ 2 and 115 Ϯ 4 mmHg in rats fed NS and HS, respectively. MAP was significantly higher in the ET B -deficient rats than their controls and averaged 132 Ϯ 5 and 131 Ϯ 5 mmHg in the NS and HS rats, respectively. Baseline RBF was greater in the Tg control rats eating HS and averaged 9.2 Ϯ 0.6 and 13.6 Ϯ 0.9 ml/min in the NS and HS groups, respectively. Baseline RBF of ET B -deficient rats averaged 7.4 Ϯ 0.6 and 7.0 Ϯ 0.5 ml/min in the NS and HS groups, respectively. Notably, HS did not increase baseline RBF in ET B -deficient rats as it did in Tg control rats. Figure 8 illustrates the effects of a HS diet on autoregulation of RBF in Tg controls and ET B -deficient rats. The autoregulatory response observed from ET B -deficient rats on NS and HS diets and the response observed in Tg control rats on NS were normal, yielding AIs of 0.26 Ϯ 0.14, 0.12 Ϯ 0.2, and 0.18 Ϯ 0.1, respectively. In contrast, HS diet significantly impaired autoregulatory behavior in the Tg control group on HS yielding an AI of 0.63 Ϯ 0.08 (P Ͻ 0.05 vs. NS).
DISCUSSION
This study employed three approaches to assess the impact of high dietary salt and endothelin receptors on autoregulation including the in vitro blood-perfused juxtamedullary nephron technique and whole kidney autoregulation using anesthetized rats. The whole kidney studies included use of normal rats and rats with a naturally occurring ET B receptor deficiency (17) . The results of the studies demonstrate that renal autoregulatory behavior is blunted in rats fed a HS diet for 14 days, consistent with our previous report (15) . This blunted autoregulatory capability involves endothelin receptor signaling primarily through ET B receptors but may also involve ET A receptors. This is supported by the observations that acute pharmacological blockade of either ET A or ET B receptors with BQ-123 or BQ-788, respectively, completely normalizes autoregulatory behavior of juxtamedullary afferent arterioles in vitro. Furthermore, rats maintained on HS and given an acute infusion of the ET B antagonist BQ-788 significantly improved whole kidney autoregulation of RBF. Notably, in vivo treatment with the ET A antagonist BQ-123 evoked no detectable improvement in the blunted autoregulation observed in HS rats when assessed over the larger pressure range from ambient MAP to 95 mmHg, but did show improvement over the range of ambient to 105 mmHg such that the AI was similar to NS controls and different from HS rats. Additionally, data from ET B -deficient rats support the hypothesis that excessive dietary salt consumption can lead to blunted renal autoregulation derived in part through endothelin activity.
The in vitro blood-perfused juxtamedullary nephron technique has been used to study the control of glomerular and renal microvascular function since 1984 (8) . Some of the earliest studies with this approach demonstrated that juxtamedullary glomerular capillary pressure and intravascular pressures along the juxtamedullary preglomerular vascular tree were autoregulated in response to step changes in renal perfusion pressure (7, 26) . Later work demonstrated that blood flow through a single juxtamedullary afferent arteriole was also autoregulated in response to a step change in perfusion pressure and that both TGF and myogenic inputs were involved in the pressure-induced resistance adjustments (61) . The work from these published reports establish that the in vitro bloodperfused juxtamedullary nephron technique is suitable for measuring juxtamedullary afferent arteriolar autoregulatory behavior.
In the current study, we used a broad pressure range extending from 65 to 170 mmHg and observed pressure-mediated vasoconstriction in NS rats over the entire range. This is consistent with good autoregulation in this nephron population. Some might consider that the pressure sensitivity observed at the lower pressure range is greater than would be predicted from whole kidney autoregulation in vivo, but it should be remembered that this is an in vitro technique that has demonstrated autoregulation of pressure and flow in response to pressure stimuli (7, 26, 61) . In addition, whole kidney autoregulatory measurements of RBF reflect renal vascular responses from the entire preglomerular vascular tree throughout the renal cortex rather than the response of a single arteriole in a single region of the kidney. Indeed, Källskog et al. (33) reported that inner cortical autoregulatory behavior was more pronounced than outer cortical autoregulation. Consequently, as one spans the autoregulatory range, autoregulatory capacity would be exhausted in some nephrons sooner than in others yielding an averaged RBF autoregulation profile where the RBF plateau would begin to roll into a more passive whole kidney pressure/flow relationship earlier in the pressure range. Comparing this with published whole kidney autoregulation data reveals that the estimated lower limit of autoregulatory capacity (arbitrarily set at 90% of baseline RBF) varies from ϳ75 to 97 mmHg in anesthetized rat studies (3, 9 -11, 19, 30,   49, 50, 52) . Thus, the in vitro data are in good qualitative agreement with in vivo data within the typical autoregulatory range.
The ability of high dietary salt to attenuate myogenic reactivity in large skeletal muscle arterioles of normotensive rats has been known for some time (46, 47) . There is convincing evidence in animal models that excessive salt consumption can lead to renal microvascular dysfunction, and glomerular injury (1, 15) . We recently demonstrated that the blunted renal autoregulatory response observed with afferent arterioles at the whole kidney level in response to high dietary salt is reversed by acute treatment with the NADPH oxidase inhibitor and/or scavenger of reactive oxygen species, apocynin (15) . HS diets are believed to reduce nitric oxide bioavailability and promote enhanced accumulation of reactive oxygen species (48) . Future studies will have to explore whether our findings that ET B receptors reduce autoregulatory reactivity under HS conditions are related to oxidative stress.
In vitro data presented here show that acute blockade of either ET A or ET B receptors normalized afferent arteriolar diameter responses to changes in renal perfusion pressure. Given the highly selective nature of these antagonists, it is interesting that either receptor antagonist was effective in this setting. One consideration for this unexpected observation is that the renal endothelin receptor system is more complex than the classical views of simple receptor/ligand activation. The idea that ET A and ET B receptors may interact with one another to yield complex physiological outcomes has been suggested before. Competitive binding studies suggested that ET B receptor-selective ligands competed with ET-1 for binding only when a selective ET A agonist was present (21) . There is evidence in astrocytes that both ET A and ET B receptors had to be blocked to prevent ET-1 clearance (23) . With respect to the renal circulation, Just et al. (32) concluded that stimulation of ET B receptors alone led to renal vasoconstriction but during costimulation of both receptor subtypes, ET B agonists produced a renal vasodilation. They concluded that there must be a more complex interaction between ET A and ET B receptors that was more than additive. Furthermore, in the juxtamedullary nephron preparation, we reported a somewhat puzzling finding that both ET A and ET B receptor antagonists equally inhibited afferent arteriolar vasoconstriction produced by low doses of ET-1 (29) . Receptor interaction is possible as ET A and ET B receptors are postulated to form homodimers and heterodimers in transfected cells (18) . This theory is interesting and clearly requires further study but it could explain the essentially equivalent beneficial effects of ET A or ET B receptor blockers on autoregulatory responses of blood-perfused juxtamedullary nephron afferent arterioles in vitro. Receptor cooperativity and postreceptor/G protein signaling could also account for these findings but more work is required to explain this phenomenon.
We extended the in vitro findings by assessing the effects of endothelin receptor antagonists on whole kidney autoregulation of RBF. Consistent with the in vitro data and with our previous whole kidney data (15) , we found that whole kidney autoregulation was significantly impaired in kidneys from rats fed HS. The whole kidney results with endothelin receptor blockers are qualitatively consistent with in vitro data in that acute ET B receptor blockade significantly improved autoregulation of RBF and autoregulation was preserved in ET B -deficient rats fed HS. Joint blockade of both ET A and ET B receptors effectively restored normal autoregulation in HS conditions in vivo. Interestingly, results with ET A receptor blockade were mixed. ET A receptor blockade conferred some restoration of autoregulatory control at higher pressures (ambient to 105 mmHg) but over the broader pressure range (ambient to 95 mmHg) there was no detectable effect on whole kidney autoregulation of RBF in vivo. The explanation for this difference in effectiveness is unclear but could reflect a number of important differences between the two experimental settings. Clearly one set of data is collected in vivo and the other in vitro. Whole kidney hemodynamics data reflect the microvascular outcomes of all of the vascular elements within the kidney, whereas the in vitro findings focus on the juxtamedullary afferent arterioles. If receptor interactions do influence the renal hemodynamic response to endothelin, there could be regional differences in how those interactions are manifested.
Another possible explanation is that the set points for the lower limit of autoregulation may have changed under HS conditions in vivo. This explanation seems unlikely though since the AI patterns were similar across groups over the ambient-to-105 mmHg and the ambient-to-95 mmHg ranges. In both cases, autoregulation of RBF was impaired in the HS group and acute joint ET A /ET B receptor blockade normalized it. In addition, AI was normal during ET B receptor blockade and in ET B -deficient rats. Interestingly, ET A receptor blockade exhibited mixed effectiveness with good restoration of RBF autoregulation at higher pressures (ambient to 105 mmHg) and poorer effectiveness at lower pressures (ambient-95 mmHg). Accordingly, overall resetting of the lower limit of autoregulation does not explain these findings. The data also seem to reveal a modulatory role for ET A receptors or an unexplained ET A /ET B receptor interaction that collectively influences autoregulatory function in HS conditions.
In comparing the in vitro findings with the in vivo findings, another similarity emerges. Based on the in vitro data presented, the pressure/diameter response of the HS group already begins deviating from the control response at perfusion pressures of ϳ95 mmHg or even 80 mmHg and is more pronounced at 110 mmHg. This leads to a clearly shallower pressure/diameter relationship in the HS animals compared with the NS controls at perfusion pressures that approximate those lower RAPs used in the in vivo experiments. The relatively unchanging arteriolar diameter from the range of 140 to 95 mmHg would result in a more passive pressure/flow relationship in vivo and would manifest as a decline in RBF as RAP is reduced over that range. Indeed, the existence of functional impairment in the in vivo autoregulatory response is supported by the fact that the AI reflecting the autoregulatory range from ambient to 95 mmHg RAP is significantly greater in the HS group than the NS group. Accordingly, there is good qualitative agreement between the trends observed in the in vitro setting and those manifested in vivo. Because of the limitations inherent in the in vivo assessment of autoregulation, we could not reliably go above the ambient blood pressure so the ability to assess higher and lower pressures with the in vitro approach compliments the in vivo data.
Another inherent issue associated with direct comparison of the in vitro data with the in vivo data is the analysis. In vitro data were analyzed based on the actual juxtamedullary afferent arteriole diameter and changes in diameter normalized to the control or starting diameter. Diameter responses were analyzed in response to increases in renal perfusion pressure up to 170 mmHg. The results indicate that the response in HS conditions was significantly shallower than the other groups and is most clearly manifested at the higher pressures. In the in vivo setting we measured whole kidney RBF responses emerging from decreases in RAP. Under these conditions, changes in RBF reflect resistance changes in all of the renal vasculature in contrast to the diameter response of a single arteriole in a single region of the kidney. Because of the challenges inherent in using artificial means to increase RAP to ϳ170 mmHg in an anesthetized rat setting, we chose to assess autoregulatory responses by manipulating RAP from ambient to 85 mmHg. Each group of rats/conditions presented with slightly different ambient RAP and ET receptor blockade tended to reduce RAP. Consequently, the analysis was conducted from ambient RAP to 85 mmHg and normalized accordingly. This approach yields what appears to be a discrepant autoregulatory profile with impairment apparent at the higher pressures in the in vitro studies and at lower pressures in the in vivo studies. The end conclusion is that autoregulatory capability is impaired under HS conditions and that it is improved by inhibition of the ET system. The directionality of whether it is at higher or lower pressures in this report is a function of the normalization and analysis.
Consistent with our in vivo findings and our previous report (15), Saeed et al. (55) reported that high dietary salt impairs dynamic autoregulation of RBF in rats infused with angiotensin II. They employed transfer function analysis to evaluate the renal myogenic response and the tubuloglomerular feedback response and found that both were significantly impaired and that the impairment could be improved by treatment with tempol. More recently, they extended those studies by assessing the impact of endothelin receptor blockade on the impaired dynamic autoregulation using an internally paired design similar to that used for our studies (54) . In addition, the treatment doses of the endothelin receptor antagonists were identical to those used in the current study. In contrast to our finding that joint administration of ET A /ET B receptor blockers or a selective ET B blocker alone markedly improved autoregulatory function, they found that endothelin receptor antagonists did not attenuate the abnormalities in dynamic autoregulation observed in their angiotensin II-infused HS model. Indeed, Kittikulsuth et al. (34) demonstrated that ET B receptor activity is decreased in angiotensin II-infused hypertension in male rats but not female rats. The reason for this discrepancy could relate to the use of a more complex experimental setting including high dietary salt and angiotensin II-induced hypertension. Both of these conditions independently have a negative impact on autoregulatory control but the mechanisms responsible for each are not understood.
Increased ET-1 production in HS conditions and impairment of renal microvascular autoregulatory efficiency could represent a physiological response of the kidney to excrete more salt. Reduced autoregulatory efficiency would facilitate subtle increases in glomerular filtration pressure to increase the filtered sodium load. Under such conditions, increased delivery of sodium to the collecting duct would exacerbate ET B receptor-dependent inhibition of tubular sodium reabsorption that occurs during HS intake, thereby maintaining sodium balance. Consequently, upregulation of the renal and vascular endothe-lin system may represent an important renal response to high dietary salt to facilitate excretion of the salt load and maintain cardiovascular homeostasis.
In summary, this study provides compelling new evidence for the hypothesis that increased salt intake leads to an endothelin receptor-dependent decrease in afferent arteriole autoregulatory behavior. This impaired autoregulatory function related to HS appears to involve ET B receptors and may also involve ET A receptors or a complex ET A /ET B receptor interaction. These observations could enhance the therapeutic potential of endothelin receptor blockers in the prevention of kidney injury due to excess salt consumption and perhaps salt-sensitive hypertension. It is interesting to speculate that in a setting of high dietary salt, endothelin signaling may be linked to increased oxidative stress previously shown to blunt autoregulatory behavior under high dietary salt conditions (15, 16, 55) . 
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